First Time Loading...

Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 107.28 USD 1.91% Market Closed
Updated: Apr 20, 2024

ROE
Return on Equity

15.2%
Current
19%
Average
3.1%
Industry
Positive for the last year
15.2%
Positive average
19%
Worse than average
Better than industry value

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
15.2%
=
Net Income
5.7B
/
Equity
37.8B

ROE Across Competitors

ROE Comparison
Abbott Laboratories Competitors

Country US
Market Cap 184.8B USD
ROE
15%
Country US
Market Cap 130.8B USD
ROE
15%
Country US
Market Cap 123.8B USD
ROE
18%
Country IE
Market Cap 105.7B USD
ROE
8%
Country US
Market Cap 98.5B USD
ROE
9%
Country US
Market Cap 67.9B USD
ROE
5%
Country DE
Market Cap 56.8B EUR
ROE
8%
Country US
Market Cap 51.7B USD
ROE
23%
Country US
Market Cap 50.4B USD
ROE
26%
Country CN
Market Cap 328.2B CNY
ROE
34%
Country US
Market Cap 39.6B USD
ROE
81%

Profitability Report

View the profitability report to see the full profitability analysis for Abbott Laboratories.

See Also

Discover More
What is Return on Equity?

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
15.2%
=
Net Income
5.7B
/
Equity
37.8B
What is the ROE of Abbott Laboratories?

Based on Abbott Laboratories's most recent financial statements, the company has ROE of 15.2%.